Ownership Summary
According to SEC filings for the period ending December 2025, Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) is held by 11 institutional firms.
- The percentage of Aimei Health Technology owned by institutions changed from 57.6% in September 2025 to 14.9% in December 2025, marking a slight down trend.
- In percentage terms, this reflects as a holdings change of -48.21% quarter on quarter, and a decrease of 54.17% year over year.
- During the quarter, 7 institutions bought more Aimei Health Technology shares, 3 sold shares, and 1 of the 11 total investors held their position steady.
- The aggregate institutional position in Aimei Health Technology now stands at 994.91K shares as of December 2025, after investors decreased their holdings (down by 926.16K shares quarter on quarter which is down 5.31Mn shares year over year).
- First Trust Capital Management L.P. continues to be the largest institutional holder of Aimei Health Technology as of December 31, 2025, with a position of 680.00K shares, representing 10.16% of the company's outstanding stock.
- Among the most significant buyers of Aimei Health Technology during December 2025 were Clear Street Group Inc. (22.29K), GEODE CAPITAL MANAGEMENT, LLC (6.45K), Dakota Wealth Management (6.35K), JANE STREET GROUP, LLC (4.72K), OSAIC HOLDINGS, INC. (717).
- Leading sellers of Aimei Health Technology stock in December 2025 included Karpus Management, Inc. (947.72K), GLAZER CAPITAL, LLC (16.36K), UBS Group AG (2.64K).
- The top 10 institutional holders of Aimei Health Technology for the quarter ending December 2025 included First Trust Capital Management L.P. (680.00K), GLAZER CAPITAL, LLC (133.74K), Clear Street Group Inc. (83.34K), Karpus Management, Inc. (78.08K), GEODE CAPITAL MANAGEMENT, LLC (6.45K), Dakota Wealth Management (6.35K), JANE STREET GROUP, LLC (4.72K), UBS Group AG (1.31K), OSAIC HOLDINGS, INC. (862), MORGAN STANLEY (32).